Radioprotective effect of transferrin targeted citicoline liposomes.
The high level of expression of transferrin receptors (Tf-R) on the surface of endothelial cells of the blood-brain-barrier (BBB) had been widely utilized to deliver drugs to the brain. The primary aim of this study was to use transferrin receptor mediated endocytosis as a pathway for the rational development of holo-transferrin coupled liposomes for drug targeting to the brain. Citicoline is a neuroprotective agent used clinically to treat for instance Parkinson disease, stroke, Alzheimer's disease and brain ischemia. Citicoline does not readily cross the BBB because of its strong polar nature. Hence, citicoline was used as a model drug. (Citicoline liposomes have been prepared using dipalmitoylphosphatidylcholine (DPPC) or distearoylphosphatidylcholine (DSPC) by dry lipid film hydration-extrusion method). The effect of the use of liposomes composed of DPPC or DSPC on their citicoline encapsulation efficiency and their stability in vitro were studied. Transferrin was coupled to liposomes by a technique which involves the prevention of scavenging diferric iron atoms of transferrin. The coupling efficiency of transferrin to the liposomes was studied. In vitro evaluation of transferrin-coupled liposomes was performed for their radioprotective effect in radiation treated cell cultures. In this study, OVCAR-3 cells were used as a model cell type over-expressing the Tf-R and human umbilical vein endothelial cells (HUVEC) as BBB endothelial cell model. The average diameter of DPPC and DSPC liposomes were 138 +/- 6.3 and 79.0 +/- 3.2 nm, respectively. The citicoline encapsulation capacity of DPPC and DSPC liposomes was 81.8 +/- 12.8 and 54.9 +/- 0.04 microg/micromol of phospholipid, respectively. Liposomes prepared from DSPC showed relatively better stability than DPPC liposomes at 37 degrees C and in the presence of serum. Hence, DSPC liposomes were used for transferrin coupling and an average of 46-55 molecules of transferrin were present per liposome. Free citicoline has shown radioprotective effect at higher doses tested. Interestingly, encapsulation of citicoline in pegylated liposomes significantly improved the radioprotective effect by 4-fold compared to free citicoline in OVCAR-3 but not in HUVEC. Further, citicoline encapsulation in transferrin-coupled liposomes has significantly improved the radioprotective effect by approximately 8-fold in OVCAR-3 and 2-fold in HUVEC cells with respect to the free drug. This is likely due to the entry of citicoline into cells via transferrin receptor mediated endocytosis. In conclusion, our results suggest that low concentrations of citicoline encapsulated in transferrin-coupled liposomes could offer therapeutic benefit in treating stroke compared to free citicoline.
Suresh Reddy
Jannapally
J
NDDS Laboratory, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, AP, 506 009, India.
Venkateswarlu
Vobalaboina
V
Koning
Gerben A
GA
D015060:1,2-Dipalmitoylphosphatidylcholine; D000818:Animals; D002460:Cell Line; D003566:Cytidine Diphosphate Choline / Q000008:administration & dosage* / Q000494:pharmacology*; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004730:Endothelium, Vascular / Q000166:cytology; D005079:Excipients; D006168:Guinea Pigs; D006801:Humans; D008081:Liposomes; D018697:Nootropic Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D011092:Polyethylene Glycols; D011837:Radiation-Protective Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D011990:Receptors, Transferrin / Q000187:drug effects*; D012756:Sheep
D004337:Drug Carriers; D005079:Excipients; D008081:Liposomes; D018697:Nootropic Agents; D011837:Radiation-Protective Agents; D011990:Receptors, Transferrin; D015060:1,2-Dipalmitoylphosphatidylcholine; D011092:Polyethylene Glycols; D003566:Cytidine Diphosphate Choline